ASCA- IgA Saccharomyces Cerevisiae
New
2,360.00₹
In stock
All over India
0 Reviews
An **ASCA-IgA (Anti-*Saccharomyces cerevisiae* Antibodies - IgA)** test is a specialized serological blood assay used in the diagnostic evaluation of Inflammatory Bowel Disease (IBD). It detects IgA-class antibodies targeted against the cell wall mannan of the yeast *Saccharomyces cerevisiae*.
This biomarker is particularly valuable in differentiating Crohn’s disease from Ulcerative Colitis, as positive ASCA-IgA levels strongly correlate with Crohn’s disease. When combined with other serological markers like pANCA, the test aids gastroenterologists in refining diagnosis, predicting disease phenotype, assessing clinical severity, and guiding personalized therapeutic strategies for long-term management of gastrointestinal inflammation.
This biomarker is particularly valuable in differentiating Crohn’s disease from Ulcerative Colitis, as positive ASCA-IgA levels strongly correlate with Crohn’s disease. When combined with other serological markers like pANCA, the test aids gastroenterologists in refining diagnosis, predicting disease phenotype, assessing clinical severity, and guiding personalized therapeutic strategies for long-term management of gastrointestinal inflammation.
An **ASCA-IgA (Anti-*Saccharomyces cerevisiae* Antibodies - IgA)** test is a specialized serological blood assay used in the diagnostic evaluation of Inflammatory Bowel Disease (IBD). It detects IgA-class antibodies targeted against the cell wall mannan of the yeast *Saccharomyces cerevisiae*.
This biomarker is particularly valuable in differentiating Crohn’s disease from Ulcerative Colitis, as positive ASCA-IgA levels strongly correlate with Crohn’s disease. When combined with other serological markers like pANCA, the test aids gastroenterologists in refining diagnosis, predicting disease phenotype, assessing clinical severity, and guiding personalized therapeutic strategies for long-term management of gastrointestinal inflammation.
